Market Reports Center One Stop Market Research Shop Gonorrhea Diagnostics Market Share, Size, Price, Growth, Trends and Forecast 2016 – 2020 Technavio Announces the Publication of its Research Report – Global Gonorrhea Diagnostics Market 2016-2020 Technavio recognizes the following companies as the key players in the global gonorrhea diagnostics market: Abbott Laboratories, Beckman Coulter, Roche Diagnostics, and Siemens. Other Prominent Vendors in the market are: Agilent Technologies, Alere, Becton Dickinson and Company, Bio-Rad, Cepheid, Diamedix, Kyowa Medex, Lonza, Mackay Life Sciences, Nihon Kohden, Ortho-Clinical Diagnostics, Polymedco, Qiagen, SDIX, Sequenom, Sienco, Sysmex, Takara Bio, and Thermo Fisher. Commenting on the report, an analyst from Technavio’ s team said: “A trend which is already contributing to market growth is the growing use of molecular diagnostics. Molecular diagnostics are used to study the chemical structure of DNA to determine the presence of an abnormal gene sequences, which could be the potential cause for the disease caused by an organism or pathogen. Therefore, physicians can isolate the specific gene polymorphisms causing the disease directly, or indirectly target DNA through amplification based on the amount of target DNA present. Molecular diagnostics represent the first step toward understanding a disease at the molecular level and is the fastest-growing clinical diagnostics technology.” Download Brochure now @ https://marketreportscenter.com/reports/313720/global-gonorrheadiagnostics-market-2016-2020 According to the report, a key growth driver is the rising number of gonorrhea cases. The incidence of gonorrhea has been on the rise worldwide. According to the CDC, gonorrhea is the second most commonly reported communicable disease after chlamydia. In 2014, as per the estimates by CDC, there were around 350,062 reported cases of gonorrhea (a rate of 110.7 per 100,000) in the US. The highest incidence of gonorrhea was observed in heterosexually infected men, especially those aged 25-34 years. During the last 10 years, women constituted only around 20%-30% of all the reported cases of gonorrhea. Further, the report states that one challenge that could restrict market growth is the lack of technical expertise. Gonorrhea diagnosis is highly complex and technical. An expert such as a specialized medical practitioner is required that can provide accurate and specific results to the patient. The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors. About the Gonorrhea Diagnostics Market Gonorrhea is a sexually transmitted disease that can affect both males and females. It is caused by the bacterium Neisseria gonorrhoeae. The bacterium grows in warm and moist areas of uterus, reproductive tract, fallopian tubes, and urethra. It can also grow and infect the throat, mouth, and anus. Women are more likely to contract this disease than men. Based on the Sexually Transmitted Disease Surveillance 2009 report, the Centers for Disease Control and Prevention (CDC) estimated that gonorrhea is the second most common communicable disease in the US. Technavio’ s analysts forecast the global gonorrhea diagnostics market to grow at a CAGR of 9.25% during the period 2016-2020. Covered in this report The report covers the present scenario and the growth prospects of the global gonorrhea diagnostics market for 2016-2020. To calculate the market size, Technavio uses revenue generated from the sales of gonorrhea diagnostics products. The market is divided into the following segments based on geography: • Americas • APAC • EMEA Technavio's report, Global Gonorrhea Diagnostics Market 2016-2020, has been prepared based on an indepth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. Key vendors • Abbott Laboratories • Beckman Coulter • Roche Diagnostics • Siemens Other prominent vendors • Agilent Technologies • Alere • Becton Dickinson and Company • Bio-Rad • Cepheid • Diamedix • Kyowa Medex • Lonza • Mackay Life Sciences • Nihon Kohden • Ortho-Clinical Diagnostics • Polymedco • Qiagen • SDIX • Sequenom • Sienco • Sysmex • Takara Bio • Thermo Fisher Request for discount @ https://marketreportscenter.com/request-discount/313720 Market driver • Increase incidence of gonorrhea • For a full, detailed list, view our report Market challenge • Lack of technical expertise • For a full, detailed list, view our report Market trend • Growing use of molecular diagnostics • For a full, detailed list, view our report Key questions answered in this report • What will the market size be in 2020 and what will the growth rate be? • What are the key market trends? • What is driving this market? • What are the challenges to market growth? • Who are the key vendors in this market space? • What are the market opportunities and threats faced by the key vendors? • What are the strengths and weaknesses of the key vendors? You can request one free hour of our analyst’ s time when you purchase this market report. Details are provided within the report. To Get Request Sample for this Reports: https://marketreportscenter.com/request-sample/313720 For more information content with us; Sam Collins Market Reports Center 1-646-883-3044 (US) [email protected] https://marketreportscenter.com
Technavio recognizes the following companies as the key players in the global gonorrhea diagnostics market: Abbott Laboratories, Beckman Coulter, Roche Diagnostics, and Siemens.
© Copyright 2024 Paperzz
